Dr. Marty Makary, President Trump's nominee to lead the Food and Drug Administration, faced questions from senators about ...

Capricor Therapeutics, Inc.'s Deramiocel receives FDA Priority Review for DMD cardiomyopathy, with a decision by Aug. 2025.

Martin Makary, President Donald Trump's nominee to run the U.S. FDA, on Thursday promised to convene the agency's vaccine ...

Marty Makary, Trump’s pick for FDA director, faces his first test as he testifies before the Senate health committee.

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple ...

A BioSpace analysis of all 80 priority review vouchers that have been handed out across the three FDA programs that offer ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on ...

REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...

Seniors battling insomnia are best off picking up some dumbbells or doing some push-ups, a new evidence review suggests.

A special committee in Albany is investigating what it says are serious and possibly even criminal allegations being made by ...

Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...